NEW YORK (AP) — He's the enfant terrible of pharmaceuticals, a 32-year-old CEO who unapologetically raised the price of the only approved drug for a rare disease from $13.50 to $750 per pill.
He's a millionaire music aficionado who riled rap fa
By Associated Press JENNIFER PELTZ ,
© Samoa Observer 2016
Developed by Samoa Observer in Apia